Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Oak
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxOak
Shoppers willing to complete a long health intake before they see a price, who want the non-injectable route on the same account as the two weekly injections and will confirm the number Oak quotes them rather than the one on its homepage.
Visit OakThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 65. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Oak still earns a C — Shoppers willing to complete a long health intake before they see a price, who want the non-injectable route on the same account as the two weekly injections and will confirm the number Oak quotes them rather than the one on its homepage.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Oak |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 65/100 |
| Semaglutide / mo | $99/mo | $250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August — fifty dollars higher than that morning |
| Tirzepatide / mo | $149/mo | $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August — fifty dollars higher than that morning |
| Semaglutide / yr (modeled) | $1,188 | — |
| Tirzepatide / yr (modeled) | $1,788 | — |
| Coverage | All 50 states | 45 states (list not published) |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #129 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Oak
65/100Where the value is
- A non-injectable route alongside the two weekly injections — sublingual drops or tablets targeting the GLP-1 pathway — which most programs at this end of the ranking do not offer at all
- LegitScript-certified, provider-reviewed, no video call required, with free shipping and free health coaching included
- Its own comparison tables do print undiscounted floors — $167/mo on the homepage, $190/mo on /weight-loss — so a reader who scrolls past the hero at least sees figures that are not a package discount in a monthly slot
The tradeoffs
- It publishes NINE different "starting" prices — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term, a plan length or a billing cadence to not one of them
- The $119 and $185 in the homepage hero appear only beside a "$200 off — new patient offer", and Oak's own affiliate page defines that offer as "$50 off your first month, $200 off 3-months" — a three-month package discount presented as a monthly rate
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.